Skip to contentHelp us improve by providing feedback or contacting help@jisc.ac.uk

Sign in with ORCID

u

unexakorea

0009-0009-7919-1770

Employment

Organisation	Role	Department	Start date	End date
unexakorea Inc.	Not specified	Not specified

Education

No history available.

Works

No works available.

Octopus publications

Showing

Method

Investigation of In Vivo Sustained-Release Formulation Technology and Pharmacokinetic Retention of Functional Ingredients

Materials and Methods●Test materials: Samples of the same-ingredient comparison group (UMFG) and (UTEV) were used.●Animal model: Male C57BL/6 mice (12 weeks old, n = 8) were employed.●Dosage: Each sample was orally administered at a dose of 1 mg/kg.●Sampling time points: Blood samples were collected at 0, 3, 6, and 24 hours after administration, and serum vitamin *...

Published November 13, 2025, by unexakorea

Interpretation

Time-Dependent Analysis of Blood Concentration of Water-Soluble Vitamin** According to the Application of the Technology

Published November 10, 2025, by unexakorea

Results / Sources

Investigation of In Vivo Sustained-Release Formulation Technology and Pharmacokinetic Retention of Functional Ingredients

ConclusionThe coating-based sustained-release formulation extended plasma vitamin levels for over 12 hours, indicating a paradigm shift from absorption-focused to stability-focused supplement design.In this study, the effects of the control group with equivalent composition (UMFG) and the Unexa Vitamin Powder (UTEV) on plasma Vitamin levels were evaluated. Both UM...

Published November 10, 2025, by unexakorea

Analysis

Investigation of In Vivo Sustained-Release Formulation Technology and Pharmacokinetic Retention of Functional Ingredients

Statistical AnalysisStatistical analyses were performed using SPSS version 23.0 (SPSS Inc., Chicago, IL, USA). Data are expressed as the mean ± standard error (Mean ± S.E.). Statistical significance between experimental groups was determined using the t-test, with p < 0.05 considered statistically significant. For relative analyses, one-way analysis of variance (AN...

Published November 10, 2025, by unexakorea

Rationale / Hypothesis

Investigation of In Vivo Sustained-Release Formulation Technology and Pharmacokinetic Retention of Functional Ingredients

This Investigation evaluated the in vivo maintenance effect of a sustained-release vitamin formulation developed using the proprietary coating technology of unexakorea Inc. In a mouse model, the formulation demonstrated a stable plasma concentration for approximately 10–12 hours after administration. These findings suggest that the sustained-release formulation may...

Published November 10, 2025, by unexakorea

Research Problem

Investigation of In Vivo Sustained-Release Formulation Technology and Pharmacokinetic Retention of Functional Ingredients

Research Problem : Investigation of In Vivo Sustained-Release Formulation Technology and Pharmacokinetic Retention of Functional Ingredients

Published November 10, 2025, by unexakorea

Red flags raised by this user

Include resolved flags